Trial · NCT02633878
Registered outcomes48
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 48
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Live birth | At or beyond 20 completed weeks' gestation | Rate of live birth at or beyond 20 completed weeks' gestation |
| Secondary | Pregnancy outcome: Ongoing pregnancy | Beyond 12 weeks' gestation | Rate of ongoing pregnancy (beyond 12 weeks' gestation) |
| Secondary | Pregnancy outcome: Miscarriage during the first trimester | During the first trimester (at or before 12 weeks' gestation) | Rate of miscarriage during the first trimester (at or before 12 weeks' gestation) |
| Secondary | Pregnancy outcome: Miscarriage during second and third trimesters | During second and third trimesters (beyond 12 weeks' gestation until 20 weeks) | Rate of miscarriage during second and third trimesters (beyond 12 weeks' gestation until 20 weeks) |
| Secondary | Pregnancy outcome: Termination | At any time during treatment (up to 2 months) and follow-up period (up to 1 year) | Rate of termination at any time during treatment and follow-up period |
| Secondary | Pregnancy outcome: Stillbirth | At or beyond 20 weeks' gestation | Rate of stillbirth (at or beyond 20 weeks' gestation) |
| Secondary | Pregnancy outcome: Induced abortion | At any time during treatment (up to 2 months) and follow-up period (up to 1 year) | Rate of induced abortion at any time during treatment and follow-up for any reasons |
| Secondary | Pregnancy outcome: Gestational age at delivery | Up to 1 day after delivery | Gestational age at delivery (weeks and days) |
| Secondary | Pregnancy outcome: Preterm birth | Birth before 37 completed weeks' gestation (up to and including 36 weeks and 6 days of gestation) | Rate of preterm birth (birth beyond 28 week and before 37 completed weeks' gestation (up to and including 36 weeks and 6 days of gestation)) |
| Secondary | Pregnancy outcome: Extreme preterm birth | Birth beyond 20 weeks and before 28 completed weeks' gestation (up to and including 27 weeks and 6 days of gestation) | Rate of extreme preterm birth (birth beyond 20 weeks and before 28 completed weeks' gestation (up to and including 27 weeks and 6 days of gestation)) |
| Secondary | Pregnancy outcome: Full-term birth | At or beyond 37 weeks' gestation, and before 42 weeks' gestation | Rate of full-term birth (at or beyond 37 weeks' gestation, and before 42 weeks' gestation) |
| Secondary | Pregnancy outcome: Post-term birth | At or beyond 42 weeks' gestation | Rate of post-term birth (at or beyond 42 weeks' gestation) |
| Secondary | Neonatal outcome: Birth weight | When neonatal is born | Birth weight of neonatal (adjusted for gestational age and sex by Chinese standards) |
| Secondary | Neonatal outcome: Small for gestational age | When neonatal is born | Rate of small for gestational age when neonatal is born |
| Secondary | Neonatal outcome: Large for gestational age | When neonatal is born | Rate of large for gestational age when neonatal is born |
| Secondary | Neonatal outcome: Congenital malformation | At any time during treatment (up to 2 months) and follow-up period (up to 1 year) | Rate of congenital malformation |
| Secondary | Other outcome: Mean score change in TCM Symptom Questionnaire | From date of randomization until the date of end of treatment, assessed up to 2 months | Mean score change in TCM Symptom Questionnaire from baseline to the end of intervention. The questionnaire covers many dimensions including symptoms (amount of vaginal bleeding, severity of abdominal pain and other general symptoms), emotional factors and so on. The minimum and maximum value are depend on the symptoms of the patient respectively. |
| Secondary | Other outcome: Mean score change in 12-Item Short-Form Health Survey | From date of randomization until the date of end of treatment, assessed up to 2 months | Mean score change in 12-Item Short-Form Health Survey from baseline to the end of intervention. The minimum value is 0 and the maximum value is 100, and higher scores mean a better outcome. |
| Secondary | Other outcome: Mean score change in Self-Rating Anxiety Scale | From date of randomization until the date of end of treatment, assessed up to 2 months | Mean score change in Self-Rating Anxiety Scale from baseline to the end of intervention. The minimum value is 20 and the maximum value is 80, and lower scores mean a better outcome. |
| Other | Safety outcomes: Serious adverse events - Acute kidney injury (AKI) | At any time during treatment (up to 2 months) and follow-up period (up to 1 year) | Rate of acute kidney injury (AKI) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02633878/registered